VEEV

Veeva Systems Inc. NYQ · VEEV

$195.38 -1.99 (-1.01%)

Extended · +1.54σ Grade B

+ Compare Open in Sniper

Price chart

Timeframe

Range

Loading…

Latest bar · VEEV

Momentum reads · latest daily bar

Last

$195.38

-1.99 (-1.01%)

Mkt cap

$31.7B

Healthcare

RSI(14)

65.4

neutral

Stochastic %K

86.8

overbought

MFI(14)

78.8

neutral

ADX(14)

27.0

trending

Green means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.

Financial overlay · last 12 quarters

The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.

Quarter	Revenue	Net income	Op income	FCF	Net margin	Op margin
2026-04-30	$0.9B	$0.3B	$0.3B	$1.1B	29.6%	30.9%
2026-01-31	$0.8B	$0.2B	$0.2B	$0.1B	29.2%	29.4%
2025-10-31	$0.8B	$0.2B	$0.2B	$0.2B	29.1%	29.7%
2025-07-31	$0.8B	$0.2B	$0.2B	$0.2B	25.4%	24.8%
2025-04-30	$0.8B	$0.2B	$0.2B	$0.9B	30.1%	30.8%
2024-10-31	$nanB	$nanB	$nanB	$nanB	nan%	nan%

Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.

Compare VEEV vs peers

Line VEEV up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.

Comparing VEEV UNH×

Sector peers + LLY + JNJ + MRK + ABBV + PFE + TMO

Popular + AAPL + MSFT + NVDA + AMZN + GOOG + META + TSLA + AVGO

Matchups NVDA · AMD · AVGO · SMCI · MU AAPL · MSFT · GOOG · META · AMZN JPM · GS · MS · BAC · C TSLA · RIVN · LCID · GM · F XOM · CVX · OXY · COP

Verdict

Weighted score 0-100 across 2 tickers · best in green

VEEV

score 14.3

2/5 inputs

Missing all valuation, growth, and quality data drives sentiment score to zero, producing catastrophic 14.3 overall despite solid momentum.

momentum 25sentiment 0

UNH

score 57.5

5/5 inputs

Balanced 50+ scores across value, growth, quality with exceptional 75 momentum from 34.67% 3M gain powers first-place finish.

value 50growth 50quality 50momentum 75sentiment 67

Metric	VEEV VEEV	UNH UnitedHealth Group Incorporated
Snapshot
Price	195.38	426.09
Day %↕	-1.01	0.64
1M %↕	19.59	4.52
3M %↕	16.51	34.67
YTD %↕	-10.98	26.66
Market cap	—	386951249920.0
ADV ($)	—	3118003879.2817383
Beta	—	0.633
OdysseyHQ zone
Current zone	Extended	Neutral
Dist 21-EMA %	6.06	1.78
Dist ATR (σ)	1.54	0.6
OdysseyHQ grade	B	C
Confluence↕	5	3
Valuation
P/E (ttm)↕	—	31.845291
P/E (fwd)↕	—	19.240608
P/S↕	—	0.86044043
EV/EBITDA↕	—	20.229
P/B↕	—	3.9526708
FCF yield↕	—	0.0457
PEG↕	—	1.45
Growth
Revenue yoy↕	—	0.02
EPS yoy↕	—	0.007
FCF yoy↕	—	—
Revenue trend 8Q
Quality
Gross margin↕	—	0.18801
Operating margin↕	—	0.080469996
Net margin↕	—	0.02678
ROE↕	—	0.121759996
ROA↕	—	0.03783
Debt / Equity↕	—	0.74
Interest cov.↕	—	4.67
Technicals
RSI(14)	65.4	57.9
MACD signal	bull	neutral
vs 50-DMA	13.91	5.76
vs 200-DMA	-6.51	24.8
vs 52w high	-37.08	-7.7
HV-30	43.5	26.9
Sentiment
Analyst rec↕	—	1.66667
Target upside↕	—	2.75
Insider buy-sell 90d↕	7	23
Risk
Short interest↕	—	2.26
Days to cover↕	—	2.55
Next earnings	2026-09-02	2026-07-16

VEEV

$195.38

-1.01%

Snapshot

Price 195.38

Day % -1.01

1M % 19.59

3M % 16.51

YTD % -10.98

Market cap —

ADV ($) —

Beta —

OdysseyHQ zone

Current zone Extended

Dist 21-EMA % 6.06

Dist ATR (σ) 1.54

OdysseyHQ grade B

Confluence 5

Valuation

P/E (ttm) —

P/E (fwd) —

P/S —

EV/EBITDA —

P/B —

FCF yield —

PEG —

Growth

Revenue yoy —

EPS yoy —

FCF yoy —

Revenue trend 8Q

Quality

Gross margin —

Operating margin —

Net margin —

ROE —

ROA —

Debt / Equity —

Interest cov. —

Technicals

RSI(14) 65.4

MACD signal bull

vs 50-DMA 13.91

vs 200-DMA -6.51

vs 52w high -37.08

HV-30 43.5

Sentiment

Analyst rec —

Target upside —

Insider buy-sell 90d 7

Risk

Short interest —

Days to cover —

Next earnings 2026-09-02

Full VEEV dashboard →

UNH

UnitedHealth Group Incorporated

$426.09

+0.64%

Snapshot

Price 426.09

Day % 0.64

1M % 4.52

3M % 34.67

YTD % 26.66

Market cap 386951249920.0

ADV ($) 3118003879.2817383

Beta 0.633

OdysseyHQ zone

Current zone Neutral

Dist 21-EMA % 1.78

Dist ATR (σ) 0.6

OdysseyHQ grade C

Confluence 3

Valuation

P/E (ttm) 31.845291

P/E (fwd) 19.240608

P/S 0.86044043

EV/EBITDA 20.229

P/B 3.9526708

FCF yield 0.0457

PEG 1.45

Growth

Revenue yoy 0.02

EPS yoy 0.007

FCF yoy —

Revenue trend 8Q

Quality

Gross margin 0.18801

Operating margin 0.080469996

Net margin 0.02678

ROE 0.121759996

ROA 0.03783

Debt / Equity 0.74

Interest cov. 4.67

Technicals

RSI(14) 57.9

MACD signal neutral

vs 50-DMA 5.76

vs 200-DMA 24.8

vs 52w high -7.7

HV-30 26.9

Sentiment

Analyst rec 1.66667

Target upside 2.75

Insider buy-sell 90d 23

Risk

Short interest 2.26

Days to cover 2.55

Next earnings 2026-07-16

Full UNH dashboard →

Earnings replay · last 0 reports

How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.

No earnings history available.

Peer comparison · Healthcare

Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.

Ticker ⇅	Mkt cap ⇅	P/E ⇅	Fwd P/E ⇅	P/S ⇅	EV/EBITDA ⇅	P/B ⇅	Gross M ⇅	Rev gr ⇅	EPS gr ⇅	FCF yld ⇅
VEEV ★	$32B	35.0	19.5	9.6	23.9	4.4	75.0%	16.3%	14.6%	3.97%
LLY	$1,051B	41.5	26.3	14.6	30.1	33.8	82.8%	55.5%	169.9%	0.87%
UNH	$387B	31.8	19.2	0.9	20.2	4.0	18.8%	2.0%	0.7%	4.57%
JNJ	$609B	29.0	19.7	6.2	18.4	7.5	68.1%	6.6%	-1.0%	—
MRK	$315B	35.9	13.2	4.8	12.1	6.9	76.7%	4.9%	—	4.46%
ABBV	$450B	124.8	15.6	7.2	17.2	-67.6	72.0%	12.4%	-46.2%	4.63%
PFE	$143B	19.1	8.8	2.3	7.6	1.6	74.8%	5.4%	-10.1%	8.67%
TMO	$198B	29.8	19.5	4.4	21.1	3.8	40.9%	6.2%	11.3%	2.79%

Auto-seeded from sector. Click any ticker to switch.

Ownership

Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.

Top institutional holders

Top-10 concentration: 33.18%

Holder	Shares	% out
Blackrock Inc.	11,558,875	7.12%
Vanguard Portfolio Management LLC	7,376,031	4.54%
Vanguard Capital Management LLC	6,670,318	4.11%
Alliancebernstein L.P.	6,271,098	3.86%
Linonia Partnership LP	4,924,626	3.03%
Principal Financial Group, Inc.	4,141,545	2.55%
State Street Corporation	3,608,655	2.22%
T. Rowe Price Investment Management,	3,405,594	2.10%
Geode Capital Management, LLC	3,312,734	2.04%
FMR, LLC	2,613,526	1.61%

Insider activity · 90d

1 buys / 0 sells · ratio 1.0 · Finnhub

Zuppas Eleni Nitsa M 6,541
Zuppas Eleni Nitsa M 33,418
Van Wagener Brian M 4,906
Van Wagener Brian F 9,325 @ $184.22
Van Wagener Brian M 10,018
Schwenger Thomas D. M 8,721
Schwenger Thomas D. F 25,449 @ $184.22
Schwenger Thomas D. M 26,566
Kondath Vipin M 502
Kondath Vipin F 2,783 @ $184.22

Analyst estimates

Finnhub

What Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.

Low

$165.0

Mean

$244.59259

High

$350.0

Analysts

Recommendation distribution · period 2026-07-01

Revision trend (2026-04-01 → 2026-07-01): net 28 → 24 -4 (net = strong_buy+buy − sell−strong_sell)

SEC filings

The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.

Form	Filed	Description	Action
4	2026-07-06	FORM 4	view ·
4	2026-07-06	FORM 4	view ·
4	2026-07-06	FORM 4	view ·
4	2026-07-06	FORM 4	view ·
4	2026-07-06	FORM 4	view ·
4	2026-06-22	FORM 4	view ·
4	2026-06-22	FORM 4	view ·
4	2026-06-22	FORM 4	view ·
4	2026-06-22	FORM 4	view ·
4	2026-06-22	FORM 4	view ·
4	2026-06-22	FORM 4	view ·
4	2026-06-22	FORM 4	view ·
4	2026-06-22	FORM 4	view ·
8-K	2026-06-18	8-K	view ·
10-Q	2026-06-05	10-Q	view ·
4	2026-06-03	FORM 4	view ·
4	2026-06-03	FORM 4	view ·
4	2026-06-03	FORM 4	view ·
4	2026-06-03	FORM 4	view ·
4	2026-06-03	FORM 4	view ·
4	2026-06-03	FORM 4	view ·
4	2026-06-03	FORM 4	view ·
4	2026-06-03	FORM 4	view ·
8-K	2026-06-03	8-K	view ·
4	2026-05-04	FORM 4	view ·
DEF 14A	2026-05-04	DEF 14A	view ·
8-K	2026-04-20	8-K	view ·
4	2026-04-14	FORM 4	view ·
4	2026-04-09	FORM 4	view ·
4	2026-04-09	FORM 4	view ·
4	2026-04-09	FORM 4	view ·
4	2026-04-09	FORM 4	view ·
4	2026-04-09	FORM 4	view ·
4	2026-04-03	FORM 4	view ·
4	2026-04-03	FORM 4	view ·
4	2026-04-03	FORM 4	view ·
4	2026-04-03	FORM 4	view ·
4	2026-04-03	FORM 4	view ·
10-K	2026-03-20	10-K	view ·
4	2026-03-09	FORM 4	view ·
8-K	2026-03-04	8-K	view ·
4	2026-03-03	FORM 4	view ·
4	2026-03-03	FORM 4	view ·
4	2026-03-03	FORM 4	view ·
4	2026-03-03	FORM 4	view ·
4	2026-03-03	FORM 4	view ·
4	2026-03-03	FORM 4	view ·
4	2026-03-03	FORM 4	view ·
4	2026-03-03	FORM 4	view ·
4	2026-01-15	FORM 4	view ·
4	2026-01-05	FORM 4	view ·
4	2026-01-05	FORM 4	view ·
4	2026-01-05	FORM 4	view ·
4	2026-01-05	FORM 4	view ·
4	2026-01-05	FORM 4	view ·
8-K	2026-01-05	8-K	view ·
4	2025-12-11	FORM 4	view ·
8-K	2025-12-11	8-K	view ·
4	2025-12-03	FORM 4	view ·
4	2025-12-02	FORM 4	view ·

About VEEV

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud, such as Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics. In addition, the company offers Veeva Development Cloud consisting of Veeva Clinical Platform, which advances clinical trial execution; Veeva Clinical Data Management that helps sponsors and CROs design and run trials; Veeva Safety, which unifies systems and processes; Veeva RIM that provides regulatory information management capabilities, as well as Veeva Quality Cloud, which i…

Options picks · VEEV

ITM + OTM ideas from the latest scan

Loading…

Congress trades · VEEV

STOCK Act disclosures

Loading…

SEC filings & insiders · VEEV

EDGAR · live

Loading…

Holders · VEEV

Institutions & insider activity

Loading…

Veeva Systems Inc. NYQ · VEEV

Price chart

Latest bar · VEEV

Financial overlay · last 12 quarters

Compare VEEV vs peers

Earnings replay · last 0 reports

Peer comparison · Healthcare

Ownership

Top institutional holders

Insider activity · 90d

Analyst estimates

SEC filings

About VEEV

Options picks · VEEV

Congress trades · VEEV

SEC filings & insiders · VEEV

Holders · VEEV

Filing summary